相似文献
1
Towards Personalized Treatment and Molecular Research on Gastrointestinal Tumors.
Int J Mol Sci. 2023 Sep 19;24(18):14283. doi: 10.3390/ijms241814283.
2
Introduction: personalized medicine in gastrointestinal cancer.
J Gastrointest Surg. 2012 Sep;16(9):1639-40. doi: 10.1007/s11605-012-1948-9. Epub 2012 Jun 30.
3
[Personalized tumor therapy for gastrointestinal tumors].
Internist (Berl). 2015 Sep;56(9):1069-78. doi: 10.1007/s00108-015-3752-6.
4
Overview of personalized medicine in GI cancers.
J Gastrointest Surg. 2012 Sep;16(9):1641-4. doi: 10.1007/s11605-012-1949-8. Epub 2012 Jun 29.
5
Biomarkers for personalized medicine in GI cancers.
Mol Aspects Med. 2015 Nov;45:14-27. doi: 10.1016/j.mam.2015.06.002. Epub 2015 Jun 6.
6
Molecular diagnostics and therapies for gastrointestinal tumors: a real-world experience.
J Cancer Res Clin Oncol. 2022 Aug;148(8):2137-2144. doi: 10.1007/s00432-021-03774-5. Epub 2021 Aug 26.
7
Personalized Clinical Decision Making in Gastrointestinal Malignancies: The Role of PET.
PET Clin. 2016 Jul;11(3):273-83. doi: 10.1016/j.cpet.2016.02.005. Epub 2016 Apr 25.
8
Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona.
Eur J Cancer. 2017 Nov;86:305-317. doi: 10.1016/j.ejca.2017.09.021. Epub 2017 Oct 21.
9
Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe.
Ann Oncol. 2022 Nov;33(11):1200-1202. doi: 10.1016/j.annonc.2022.07.006. Epub 2022 Aug 1.
10
SCRUM-Japan GI-SCREEN and MONSTAR-SCREEN: Path to the realization of biomarker-guided precision oncology in advanced solid tumors.
Cancer Sci. 2021 Nov;112(11):4425-4432. doi: 10.1111/cas.15132. Epub 2021 Sep 16.
引用本文的文献
1
Advances in the diagnosis and treatment of MET-variant digestive tract tumors.
World J Gastrointest Oncol. 2024 Nov 15;16(11):4338-4353. doi: 10.4251/wjgo.v16.i11.4338.
本文引用的文献
1
Genetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test?
Int J Mol Sci. 2023 Jan 21;24(3):2137. doi: 10.3390/ijms24032137.
2
Cancer statistics, 2023.
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
Prognostic Significance of mRNA Expression in Colon Cancer.
Int J Mol Sci. 2022 Apr 20;23(9):4556. doi: 10.3390/ijms23094556.
4
Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers.
Int J Mol Sci. 2022 Jan 20;23(3):1109. doi: 10.3390/ijms23031109.
5
Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients.
Int J Mol Sci. 2021 Dec 30;23(1):403. doi: 10.3390/ijms23010403.
Zotero 插件